{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:28:21Z","timestamp":1789093701596,"version":"build-2803163510"},"reference-count":22,"publisher":"Wiley","issue":"12","license":[{"start":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T00:00:00Z","timestamp":1526428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2018,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>A lack of access to methotrexate levels is common in low\u2010 and middle\u2010income countries (LMIC), relevant for 80% of children with cancer worldwide. We evaluated whether high\u2010dose methotrexate (HD\u2010MTX) can be administered safely with extended hydration and leucovorin rescue, with monitoring of serum creatinine and urine pH.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The prospective study was conducted at a single centre in Chandigarh, India in 2015. Patients with B\u2010cell acute lymphoblastic leukemia (ALL) or with T\u2010cell ALL or non\u2010Hodgkin lymphoma (T\u2010NHL) were administered 3 and 5 gm\/m<jats:sup>2<\/jats:sup> of MTX (24\u00a0hr infusion), respectively. Six doses of leucovorin (15\u00a0mg\/m<jats:sup>2<\/jats:sup>\/dose), instead of recommended three (for optimally reduced levels) at standard timing (42\u00a0hr from start of HD\u2010MTX) were administered. Hydration (125\u00a0ml\/m<jats:sup>2<\/jats:sup>\/hr) was continued for 72\u00a0hr, instead of the recommended 30\u00a0hr. Hydration fluid consisted of 0.45% sodium chloride, 5% dextrose, 7.5% sodium bicarbonate (50 mmol\/l) and potassium chloride (20 mmol\/l). Serum creatinine and urine pH were measured at baseline, 24 and 48\u00a0hr. The volume of hydration was increased (200\u00a0ml\/m<jats:sup>2<\/jats:sup>\/hr) for a serum creatinine\u00a0&gt;\u00a01.25 times the baseline.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The study included 100 cycles of HD\u2010MTX in 53 patients: B\u2010ALL 25 patients (51 cycles), T\u2010ALL 16 patients (28 cycles), T\u2010NHL 10 patients (18 cycles), and relapsed ALL 2 patients (3 cycles). The mean age was 6.8\u00a0\u00b1\u00a03.2 years. Patients were underweight in 15 (15%) cycles. Patients in 23% of cycles had a rise in creatinine to &gt;1.25 times the baseline. Toxicities (NCI CTCAE v4.0) included mucositis (32%), diarrhoea (10%), and febrile neutropenia (9%). One patient died from dengue shock syndrome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>It is safe to administer 3 or 5 gm\/m<jats:sup>2<\/jats:sup> of MTX (24\u00a0hr infusion) without measuring MTX levels, with extended hydration, additional doses of leucovorin, and monitoring of serum creatinine and urine pH.<\/jats:p><\/jats:sec>","DOI":"10.1002\/pbc.27241","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T18:37:12Z","timestamp":1526495832000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Improving the safety of high\u2010dose methotrexate for children with hematologic cancers in settings without access to MTX levels using extended hydration and additional leucovorin"],"prefix":"10.1002","volume":"65","author":[{"given":"Kalthi","family":"Vaishnavi","sequence":"first","affiliation":[{"name":"Hematology\u2010Oncology Unit, Department of Pediatrics, Advanced Pediatrics Centre Post Graduate Institute of Medical Education and Research  Chandigarh India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1009-7649","authenticated-orcid":false,"given":"Deepak","family":"Bansal","sequence":"additional","affiliation":[{"name":"Hematology\u2010Oncology Unit, Department of Pediatrics, Advanced Pediatrics Centre Post Graduate Institute of Medical Education and Research  Chandigarh India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9071-7651","authenticated-orcid":false,"given":"Amita","family":"Trehan","sequence":"additional","affiliation":[{"name":"Hematology\u2010Oncology Unit, Department of Pediatrics, Advanced Pediatrics Centre Post Graduate Institute of Medical Education and Research  Chandigarh India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richa","family":"Jain","sequence":"additional","affiliation":[{"name":"Hematology\u2010Oncology Unit, Department of Pediatrics, Advanced Pediatrics Centre Post Graduate Institute of Medical Education and Research  Chandigarh India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savita Verma","family":"Attri","sequence":"additional","affiliation":[{"name":"Biochemistry Unit, Department of Pediatrics, Advanced Pediatrics Centre Post Graduate Institute of Medical Education and Research  Chandigarh India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,5,16]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00262416"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-007-0550-4"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-04-1616"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.291.20.2471"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-013-2319-2"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20032"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-911X(200002)34:2<143::AID-MPO15>3.0.CO;2-1"},{"key":"e_1_2_8_9_1","unstructured":"A collaborative multicentre national trial for newly diagnosed patients with acute lymphoblastic leukemia. Indian Childhood Collaborative Leukemia Group. v1.0;2014."},{"key":"e_1_2_8_10_1","unstructured":"National Cancer Institute National Institute of Health. Common terminology criteria for adverse events.2010.https:\/\/evs.nci.nih.gov\/ftp1\/CTCAE\/CTCAE_4.03\/CTCAE_4.03_2010-06-14_QuickReference_5x7.pdf"},{"key":"e_1_2_8_11_1","volume-title":"Anthro (version 3.2.2) and macros","author":"WHO","year":"2011"},{"key":"e_1_2_8_12_1","volume-title":"AnthroPlus for Personal Computers: Software for Assessing Growth of the World's Children and Adolescents","author":"WHO","year":"2009"},{"key":"e_1_2_8_13_1","volume-title":"Global Database on Child Growth and Malnutrition","author":"WHO","year":"2016"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-002-0552-1"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.3109\/08880018.2015.1087612"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/751703"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2404404"},{"key":"e_1_2_8_18_1","first-page":"2","article-title":"Brainstorming random queries on childhood acute lymphoblastic leukemia","volume":"2","author":"Bansal D","year":"2014","journal-title":"PHO Bulletin"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24081"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0164"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2013.05.005"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2014.04.002"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.4081\/idr.2009.1338"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.27241","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.27241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T16:10:15Z","timestamp":1694794215000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.27241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,16]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["10.1002\/pbc.27241"],"URL":"https:\/\/doi.org\/10.1002\/pbc.27241","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,16]]},"assertion":[{"value":"2018-01-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-04-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e27241"}}